AIM ImmunoTech Inc. - 10-Q Filing
AIM ImmunoTech Inc. reports Q3 2026 financial results including detailed equity structures and ongoing clinical research expenditures.
Tickers: $AIM
AIM ImmunoTech Inc. reports Q3 2026 financial results including detailed equity structures and ongoing clinical research expenditures.
Tickers: $AIM